Angle Share Discussion Threads

[adw198] 01/5/2024 22:03

If they don’t need one prior to Q2 25 then something has gone seriously well, way beyond the company’s own projections. If that’s turns out to be the case the share price would be entitled to be MULTIPLIES of today’s price.

If you’re invested here and not expecting a raise then I think it’s based on nothing more than crossing your fingers and guessing they’ll massively exceed their own forecasts.

[boris cobaka] 01/5/2024 20:26

Some are more desperate than the CO. for a cash raise...

[adw198] 01/5/2024 19:06

The company told us when cash would run out but you seem to think you know better.
But you don’t want to explain any reasoning beyond a 12month old RNs with zero figures mentioned.

So why would I pick up the phone and ask them if there’s an update to the market guidance they’ve provided based on jenko thinking a windfall is coming?!

[jelenko] 01/5/2024 18:59

No idea if I knew I would be an "insider" which I would rather not be. The company wrote the article so I suggest you ask them, go on be brave pick up the phone.

[adw198] 01/5/2024 18:48

@jelenko….its not unreasonable of you think that RNS implies a level of income that might move the current budgeted runway until Q2.

But rather than somewhat defensively slate those of us who instead point to the most recent statements on the funding gap, perhaps you could clarify how much the bioview partnership will deliver, when and whether the company themselves considered this in their calcs in terms of revenue?

[washingmachine] 01/5/2024 18:19

I’m 100 percent with you Arthur

I’ve said before
They will go for approximately 10 million
100 million shares at 10 pence
More than likely already forward sold
Results are over due
Just get it all out of the way Andrew !

[jelenko] 01/5/2024 18:05

Doubt it myself knowing how the company are thinking at the moment. It will be an absolute last resort I can say that.

[arthur_lame_stocks] 01/5/2024 17:59

jelenko

For what it's worth I remain a holder but I think a fundraise is highly likely in the coming months.

[jelenko] 01/5/2024 17:52

I think those people desperate to peddle the fundraise bike in the absence of anything else to hang their hat on would do well to read the following that was published by AGL at the time the BioView HER2 assay project started around a year ago and as we know the assay is now completed, say no more!!


"This changing market dynamic has provided ANGLE and BioView with a major commercial opportunity to develop a quantitative CTC-based HER2 assay, to assess HER2 protein expression and/or gene amplification levels by analysing fluorescence intensities. This would be the only product-based solution on the market for this purpose leveraging both companies' previous FDA product clearances. Unlike current standard of care tests developed for use on FFPE tissue, a CTC HER2 assay could be used for longitudinal monitoring of HER2 status throughout disease progression, thereby ensuring the patient is targeted for the most appropriate treatment at every stage. The development phase is estimated to take around a year to complete with the assay development work generating c. GBP1.2 million of revenues for ANGLE".

Given the significant third-party interest in a new assay for quantitative HER2 analysis based on CTCs, ANGLE and BioView have agreed to allow for the inclusion of third parties in this project and its funding as we move into the commercialisation stage after the initial development work is complete. The parties are continuing to discuss strategic routes to market with potential corporate partners.

[boris cobaka] 01/5/2024 11:58

No City. Volume non existent at the mo. The calm before the longer calm???

Sell in May, go away come back on St Swithin's day....

[gspanner] 01/5/2024 10:14

To be fair ohwhat you are better at you job than most.

[citys2874] 01/5/2024 10:01

strong buying pressure this morning hopefully rally today

[ohwhatfun] 01/5/2024 09:36

Bag

Perhaps it’s because we have seen so many private investors misled by companies and pump crews with ignorance of major factors which can affect investments.

AGL hit 37p in the day during January over 100% up, which attracted the pump and dump dross.

The recent news looked good, the tech is good.

Time to buy??? No absolutely not to a sober head. Who new would buy when the chance of a high dilution discounted raise is on the cards.

We can’t predict unknown potential good news events, those are gambling good luck events.

AZ news came and so did the pump crew but the Jan previous spike event didn’t happen.

What we do know is the cash burn rate, talk of later than expected progress, aka forecasts missed, with £6.6m (triple 2023) revenue forecast for 2024.
But the big point is cash needed. Last 3 raises £18m and £20m twice.

Depending if they are hitting sales forecasts, the money runs out somewhere between end of year and Q2 2025.

Year end results due now (going by previous years) then the matter of fund raising will kick in. Unless of course all is on track, no deviation news needed (forecast missed) and raise chat is already in play.

Time will tell.

And to the other poster, what has shorting got to do with anything, shorter target crazy valuation retail flooded shares where raises are needed, nailed on good returns there. I don’t consider AGL to be in that situation, It was not too long ago, but has fallen for some time.

It won’t be too long before the cash situation is resolved. A number of previous backers are well out of pocket they will want special treatment.

Until funding is sorted many won’t buy , regular holders will have sold some or all, waiting for the raise, to get back in.

[spa362] 01/5/2024 09:12

Time to rise again

[gspanner] 01/5/2024 09:05

Unfortunately I don’t think there is any parsortix analysis going on Mr K. 300k participants would goose the share price a little mind you… The ctDNA companies have really cornered the market in screening studies… By virtue of investing millions in studies to be fair.

[mrkeysersoze] 01/5/2024 08:34

Fhmktg, a number of the Professor's running the Transform trial have links to Parsortix.Full article in the Guardian for those with no Telegraph access.https://www.theguardian.com/society/2024/may/01/prostate-cancer-screening-methods-trialled-in-pivotal-momentIt's not clear if Parsortix is being used, it will be on the Clinical Trials sites but I can't find it as yet as this outlines the full scope of the trial.Mark Emberton Professor of Interventional Oncology at UCL he leads a clinical innovation team that majors in experimental medicine by combining bio-engineering and nanotechnology with early phase trials in men with prostate cancer.Professor Mark Emberton, Professor of Interventional Oncology at University College London. Working to improve diagnosis and treatment for men using new imaging techniques and less invasive treatmentshttps://www.londonurologyspecialists.co.uk/team_member/professor-mark-emberton/https://prostatecanceruk.org/research/transform-trialMr K.

[sawney] 01/5/2024 07:30

Certain amount of truth in that...it's now 2 years since FDA...it's been jam tomorrow for a long time but good or bad...I'm still in for the long haul..."One day Thomas".....

[fhmktg] 01/5/2024 07:09

Prostate emerging again as a major interest area for oncology

Liquid biopsy will hopefully feature alongside MRI and patient profiling for genetic trends.

[bagpuss67] 30/4/2024 20:29

So many threads full of uninvested pontificaters. Just repeating the same thing over and over. I don't understand the social phenomenon that leads people to do this. This is a different crew to "new profile" derampers. These are some sort of person that derives pleasure from spending their time talking about shares rather than investing in them

[ohwhatfun] 30/4/2024 20:18

Krypton

And anyone also knows there is a mechanism to reduce the nominal value if they can’t get backers at 10p.

The good news is the company value is not crazy. The bad is the likely cash level needed v the share price.

If you have 260m shares in issue (MC £36m) at 14p and need £20m at 10p, that would mean 460m shares, say 11p open making the MC £50m, yet the burn is over 1m per month.

So the claims of below 10p are not fantasy, countless AIM companies have seen share prices destroyed and diluted to oblivion in this market.

Angle fortunately have something of apparent value, but years of lack of uptake will be used as leverage against them to push them lower.

It’s a bad bargaining position start point.

To be concluded in the coming weeks no doubt. Until it’s done everyday (without major deal news) is a gloomy day.

Let’s hope results don’t have any, lower than expected, pushed into 2025 etc as the vultures will have even more discount ammo.

[5oletrader] 30/4/2024 17:49

• NEW RESEARCH in Sheffield to investigate protein that fuels BREAST cancer.• Breast Cancer Now has awarded £250k to Dr Elena Rainero at the UNIVERSITY of SHEFFIELD, to study how BREAST cancer cells use alternative food sources to grow and spread, and the role a protein called a2b1 integrin plays in this process.• This research COULD uncover a cancer-specific process which may lead to the development of treatments that come with fewer side effects for patients, as healthy cells won't be affected.Https://oncologynewstoday.co.uk/new-research-in-sheffield-to-investigate-protein-that-fuels-breast-cancer/-INTERESTINGLY (above):• Will use MOUSE MODELS to block integrin a2b1 with drugs and assess the impact this has on a tumour's growth and spread to other parts of the body – when it spreads the disease becomes INCURABLE secondary BREAST cancer.-MORE INTERESTINGLY:• ANGLE announced in DEC23 research that used the parsortix system in PRE-CLINICAL MOUSE MODELs unlocking OPPORTUNITIES for DRUG DISCOVERY.• This research provides further evidence of the capability of the Parsortix system to be used for the harvesting of CTCs for analysis in pre-clinical mouse models.Https://www.londonstockexchange.com/news-article/AGL/parsortix-unlocks-opportunities-for-drug-discovery/16245716-LASTLY:• It looks as though the University of Sheffield USE and have PARSORTIX. I found a link in their 'equipment catalogue'.Https://equipment.shef.ac.uk/items/739372-

[gspanner] 30/4/2024 16:48

Anyone heard of Robert Zeillinger before or any Angle involvement? He appears to have a medical diagnostics company and been involved in funding the above research…